Hirotsugu Kenmotsu, Yasutaka Watanabe, Shoichi Itoh, Eiki Ichihara, Hiroshi Tanaka, Koichi Azuma, Ryo Arai, Shoichi Kuyama, Hiroaki Akamatsu, Kohei Otsubo, Hitomi Ajimizu, Yosuke Seto, Ken Uchibori, Hidetoshi Hayashi, Eisaku Miyauchi, Yuichi Ozawa, Naoki Ishizuka, Yuki Nakagawa, Ryohei Katayama. "Resistance mechanisms and efficacy of first-line alectinib and sequential treatments in advanced
                    <i>ALK</i>
                    + NSCLC: Real-world outcomes from a multicenter, observational study in Japan (ALCURE).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8604